We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
St. Jude Medical and Johnson & Johnson (J&J) have reported higher third-quarter earnings, reflecting strong demand for their cardiac device products. Baxter International, meanwhile, saw its earnings drop on tax charges.
Manufacturers that reprocess single-use devices (SUDs) must attach to the product a prominent and conspicuous mark identifying the firm's name or recognized symbol, according to a new FDA draft guidance that offers practical suggestions for acceptable corporate identifiers.
AdvaMed recently reported that its member companies have contributed more than $24 million in medical supplies and cash to aid the victims of Hurricane Katrina.
Reps. David Hobson (R-Ohio) and John Tanner (D-Tenn.), the co-sponsors of legislation amending competitive acquisition provisions of the Medicare Rx Law, are considering attaching their bill to must-pass legislation because of concerns that controversy over the law would thwart any effort to pass the bill as a stand-alone, a Tanner spokesman says.
The European Commission approved Johnson & Johnson’s (J&J’s) planned $25.4 billion takeover of medical devicemaker Guidant Aug. 25, subject to a number of conditions regarding fair competition practices.
Gambro Dasco, a unit of Gambro Renal Products, has issued a worldwide safety alert for all catalog numbers of its Prisma System after becoming aware of “several serious injuries and deaths” involving patients using the system.